Medical Communications

NICE has published final draft guidance recommending the use of Pfizer’s Xeljanz (tofacitinib) as an option for treating active polyarticular …

The MHRA has approved the use of Pfizer and AstraZeneca’s COVID-19 vaccines for the planned booster programme this winter. However, …

NHS patients will be the first in Europe to receive a new drug that can prevent lung cancer tumour growth, …

Vor Biopharma has announced that the FDA has granted their acute myeloid leukemia (AML) engineered hematopoietic stem cell therapy (eHSC), …

The highly anticipated trials of Elizabeth Holmes, founder and former CEO of the now-defunct Theranos, have commenced. Prosecutors are to …

NICE has updated its guidelines on the management of type 2 diabetes, recommending wider use of SGLT2 inhibitors in those …

BioMarin Pharma has announced that the FDA has slapped a clinical hold on its Phase 1/2 trial of its candidate …

Researchers have found that a booster shot of Sinovac’s COVID-19 vaccine reverses a decline in antibody activities against the Delta …

The Vaccine Minister, Nadhim Zahawi, has confirmed that vaccine passports will be required in nightclubs and other indoor venues at …

A new report from the WHO has predicted the number of people suffering from dementia is set to rise by …

NICE has approved secukinumab (Cosentyx) as an option for treating moderate to severe plaque psoriasis in people aged six to …

Novartis has announced that trials investigating CFZ533 (iscalimab) in kidney transplant patients has been halted after interim data show it …

AstraZeneca has gained EU approval for its rare blood disorder drug, Ultomiris, for use in children. The drug was developed …

The US Congress has requested data and documents from the FDA in relation to its accelerated approval of the controversial …

Researchers at King’s College London have found that being fully vaccinated against COVID-19 not only cuts the risk of catching …